内容摘要：A supporter of Lenia Batres, who is running for election for the Mexican Supreme Court, holds an instruction sheet on how to vote, during her closing campaign rally in Mexico City, Wednesday, May 28, 2025. (AP Photo/Fernando Llano)

A supporter of Lenia Batres, who is running for election for the Mexican Supreme Court, holds an instruction sheet on how to vote, during her closing campaign rally in Mexico City, Wednesday, May 28, 2025. (AP Photo/Fernando Llano)

KENNEDY, in interview with Sean Hannity that aired on Fox News on March 11: “There are adverse events from the vaccine. It does cause deaths every year. It causes — it causes all the illnesses that measles itself causes, encephalitis and blindness, et cetera. And so people ought to be able to make that choice for themselves.”THE FACTS: The measles vaccine is safe and its risks are lower than the risks of complications from measles. There have been no documented deaths from the MMR vaccine in healthy, non-immunocompromised people, according to the

Most people who get the MMR vaccine have no serious problems from it, the. The most common side effects are mild: a sore arm, fever, mild rash and temporary joint pain or stiffness in teenage or adult women who don’t already have rubella immunity. There is a very small risk of febrile seizures that increases as infants get older, which is why the shot is recommended as early as possible.Some people can have allergic reactions; people allergic to the antibiotic neomycin should not get the shot,

KENNEDY, in an April interview with CBS: “We’re always going to have measles, no matter what happens, as the (MMR) vaccine wanes very quickly.”THE FACTS: The measles vaccine is highly protective and lasts a lifetime for most people. Two doses of the vaccine are 97% effective against the virus,

Before the vaccine was introduced in 1963, the U.S. saw some

per year. Now, it’s usually fewer than 200 in a normal year.“I am happy,” Diene said, smiling. “I hope to keep improving.”

While efforts like these help patients, they also allow doctors to collect data—and that’s vital for rare disease research, policy and drug development, said Lauren Moore, chief scientific officer at the National Ataxia Foundation.“The most prevalent diseases get the most attention and the most funding,” she said. “Data … really is the first step.”

A $50,000 grant from the foundation allows Rodriguez and colleagues to enroll study participants in Senegal and Nigeria with inherited ataxias—which can lead to muscle weakness, loss of mobility, hearing and vision difficulties and life-shortening heart problems.Pathe Gueye, left, and Ndeye Lam, right, stand on their roof in Dakar, Senegal Saturday, Jan. 11, 2025. Their daughter Mariama died at age 13 of a rare genetic disease. (AP Photo/Annika Hammerschlag)